| 1 |
30864713 | CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity. | 2019 May |
1 |
| 2 |
30030044 | The GM2 ganglioside inhibits iNKT cell responses in a CD1d-dependent manner. | 2018 Sep |
1 |
| 3 |
27195112 | Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents. | 2016 Apr |
1 |
| 4 |
26260288 | STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis. | 2015 Nov |
1 |
| 5 |
25381357 | Role and regulation of CD1d in normal and pathological B cells. | 2014 Nov 15 |
2 |
| 6 |
23995283 | Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. | 2013 Oct |
1 |
| 7 |
24248359 | Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation. | 2013 Dec 3 |
1 |
| 8 |
21454514 | Binding strength and dynamics of invariant natural killer cell T cell receptor/CD1d-glycosphingolipid interaction on living cells by single molecule force spectroscopy. | 2011 May 6 |
2 |
| 9 |
18930085 | Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway. | 2009 Jan 5 |
2 |
| 10 |
18713998 | Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors. | 2008 Sep 1 |
2 |
| 11 |
17312126 | IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. | 2007 Mar 1 |
1 |
| 12 |
17599630 | Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C. | 2007 Sep |
1 |
| 13 |
16651387 | Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition. | 2006 May 15 |
1 |
| 14 |
15665086 | Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. | 2005 Feb 1 |
1 |
| 15 |
16007091 | Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. | 2005 Aug |
1 |
| 16 |
12695492 | CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. | 2003 Apr 21 |
1 |
| 17 |
12763683 | Innate immune responses support adaptive immunity: NKT cells induce B cell activation. | 2003 Jun 1 |
1 |
| 18 |
12023346 | Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. | 2002 Jun 1 |
1 |
| 19 |
10884613 | CD1-mediated antigen presentation of glycosphingolipids. | 2000 May |
2 |